Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

SISP:s delegation within AI och Health

Reference number
Coordinator Thermaiscan Technology AB
Funding from Vinnova SEK 25 000
Project duration October 2023 - December 2023
Status Completed
Venture 2023-00007-en

Important results from the project

** Denna text är maskinöversatt ** To gain a better understanding of India as a market and the ecosystems that exist within innovation in the cities of New Delhi and Hyderabad. To meet hospitals and other healthcare facilities that can potentially participate in clinical trials and then become users who pay for our AI-powered breast cancer pre-screening tool.

Expected long term effects

** Denna text är maskinöversatt ** We made new contacts and came up with several steps in a process to plan a clinical trial with the hospital in New Delhi. With capital, we can issue a clinical trial at the hospital we visited in New Delhi.

Approach and implementation

** Denna text är maskinöversatt ** Generally good arrangement of the trip and its meetings. It was quite a lot. Well arranged by the leaders.

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 9 February 2024

Reference number 2023-02559